ABL Europe SAS – GMP Production Facility
4 Rue Laurent Fries
Phone: +33 3 88 55 10 00
For directions and a map of our Strasbourg facility, click here.
ABL’s Strasbourg facility, operated under ABL Europe SAS, serves as the European contract manufacturing arm of ABL. The facility is dedicated to producing virus vectors for gene and oncolytic therapies, as well as vaccine and other virus-based immunotherapies. Compliant with EMA, US FDA and French (ANSM) GMP regulations, the 16,000 ft2+ (1,500 m2) cutting edge facility houses four controlled and segregated manufacturing suites with airlocks, independent HVAC per suite, separate double door autoclaves for both sterilization and decontamination, and a liquid waste collection and decontaminations system. The facility also provides drug product (DP) manufacturing via an isolator-based automated vial and ampoule filling machine. ABL Europe currently manufactures preclinical (toxicology/safety materials), Phase I-III clinical trial material, and with the ability to manufacture commercial product.